ZimVie Inc.
ZIMVHealthcare · Dental Equipment & Supplies · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | |
|---|---|---|---|---|---|---|
| Revenue | $449.7M | $457.2M | $459.7M | $468.5M | $896.9M | $1.06B |
| Operating income | −$20.7M | −$30.9M | −$46.5M | $21.8M | −$222.6M | −$27.8M |
| Net income | −$25.8M | −$393.3M | −$63.9M | −$95.3M | −$179.1M | −$28.0M |
| Total assets | $753.7M | $1.21B | $1.64B | $1.83B | $1.95B | — |
| Total liabilities | $372.0M | $795.9M | $883.5M | $375.4M | $458.7M | — |
| Equity | $381.7M | $409.5M | $758.6M | $1.45B | $1.49B | $1.67B |
| EPS (diluted) | $-0.94 | $-14.87 | $-2.45 | $-3.66 | $-6.87 | — |
| Shares out. | 27.1M | 26.2M | 26.1M | 0 | 26,050 | — |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2024- Operating margin
- −4.6%
- Net margin
- −5.7%
- Return on equity
- −6.8%
- Return on assets
- −3.4%
- Return on capital (ROCE)
- −3.3%
- Liabilities / assets
- 49.4%
- Debt / equity
- 0.97×
- Book value / share
- $14.09
- Revenue growth (YoY)
- −1.6%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2024- Altman Z″ (distress)
- -0.05distress
- Accruals / assets
- −5.3%clean
- Piotroski F-Score
- 6/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 severe● 3 warning● 3 good- Altman Z″ in the distress zone
- Operating losses (negative operating margin)
- Reported a net loss
- Revenue declined year-over-year
- Conservative leverage (liabilities < 50% of assets)
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- J. Goldman & Co LpPassive (13G)Nov 14, 2025
- Glazer Capital, LlcPassive (13G)Nov 13, 2025
- Gamco Investors, Inc. Et AlActivist (13D)Oct 22, 2025
- Camber Capital Management LpPassive (13G)Aug 27, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| Oct 15, 2025 | 684,647 | 2.6 | +28.8% |
| Sep 30, 2025 | 531,525 | 1.5 | +24.9% |
| Sep 15, 2025 | 425,713 | 1.0 | -42.7% |
| Aug 29, 2025 | 743,140 | 2.1 | -8.4% |
| Aug 15, 2025 | 811,073 | 2.5 | +2.9% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Entered a material agreement · Terminated a material agreement · Completed an acquisition or disposition · New financial obligation · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylaws · Other material eventOct 20, 2025
- Shareholder vote · Other material eventOct 10, 2025
- Other material eventOct 3, 2025
- Results of operationsJul 30, 2025
- Entered a material agreement · Other material eventJul 21, 2025
- Shareholder voteMay 13, 2025
- Results of operations · Regulation FD disclosureMay 8, 2025
- Director / officer change · Regulation FD disclosureMar 13, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SCHEDULE 13G/ANov 14, 2025
- SCHEDULE 13G/ANov 13, 2025
- 15-12GFORM 15-12GOct 31, 2025
- SCHEDULE 13D/AOct 22, 2025
- 25-NSE/AOct 21, 2025
- 4Oct 20, 2025
- 4Oct 20, 2025
- 4Oct 20, 2025
- 4Oct 20, 2025
- 4Oct 20, 2025
- 4Oct 20, 2025
- 4Oct 20, 2025
- 4Oct 20, 2025
- 4Oct 20, 2025
- S-8 POSOct 20, 2025
Corporate family
Spun off from Zimmer Biomet HoldingsZBH · Feb 2, 2022
From the spin-off filings we track. Follow a company to walk its own history.